At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers. We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. The Strategy Director, Commercial Learning & Development (CL+D) – HIV PrEP is responsible for shaping and driving the endtoend strategical learning strategy for Gilead’s HIV Prevention (PrEP) commercial organization. This role ensures learning solutions are tightly aligned to brand strategy, launch priorities, and evolving customer and market needs. Operating as a senior individual contributor, this role partners closely with the PrEP field ecosystem (PS, FAS, NE, FRM) and crossfunctional stakeholders to enable strong launch readiness, sustained capability development, and field performance competencies. While this role does not directly manage people, it plays a critical role in strategic leadership, influence, and support of CL+D execution and priorities, reporting directly to the Senior Director.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
5,001-10,000 employees